Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1964 Oct;43(10):2009–2015. doi: 10.1172/JCI105075

Plasma Clearance of dl-β-H3-Norepinephrine in Normal Human Subjects and Patients with Essential Hypertension*

Stanley E Gitlow 1,2, Milton Mendlowitz 1,2, Elizabeth Kruk Wilk 1,2, Sherwin Wilk 1,2, Robert L Wolf 1,2, Nosrat E Naftchi 1,2
PMCID: PMC289646  PMID: 14236225

Full text

PDF
2009

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AXELROD J., TOMCHICK R. Activation and inhibition of adrenaline metabolism. Nature. 1959 Dec 26;184(Suppl 26):2027–2027. doi: 10.1038/1842027a0. [DOI] [PubMed] [Google Scholar]
  2. AXELROD J., WEIL-MALHERBE H., TOMCHICK R. The physiological disposition of H3-epinephrine and its metabolite metanephrine. J Pharmacol Exp Ther. 1959 Dec;127:251–256. [PubMed] [Google Scholar]
  3. BEIN H. J., GROSS F., TRIPOD J., MEIER R. Experimentelle Untersuchungen über Serpasol (Reserpin), ein neues, sehr wirksames Rauwolfiaalkaloid mit neuartiger zentraler Wirkung. Schweiz Med Wochenschr. 1953 Oct 17;83(42):1007–1012. [PubMed] [Google Scholar]
  4. CROUT J. R., PISANO J. J., SJOERDSMA A. Urinary excretion of catecholamines and their metabolites in pheochromocytoma. Am Heart J. 1961 Mar;61:375–381. doi: 10.1016/0002-8703(61)90609-3. [DOI] [PubMed] [Google Scholar]
  5. DENGLER H. J., SPIEGEL H. E., TITUS E. O. Uptake of tritium-labeled norepinephrine in brain and other tissues of cat in vitro. Science. 1961 Apr 7;133(3458):1072–1073. doi: 10.1126/science.133.3458.1072. [DOI] [PubMed] [Google Scholar]
  6. DOYLE A. E., FRASER J. R. Essential hypertension and inheritance of vascular reactivity. Lancet. 1961 Sep 2;2(7201):509–511. doi: 10.1016/s0140-6736(61)92953-1. [DOI] [PubMed] [Google Scholar]
  7. GITLOW S. E., MENDLOWITZ M., KHASSIS S., COHEN G., SHA J. The diagnosis of pheochromocytoma by determination of urinary 3-methoxy-4-hydroxymandelic acid. J Clin Invest. 1960 Jan;39:221–226. doi: 10.1172/JCI104022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. GITLOW S. E., MENDLOWITZ M., SMITH A., GALL E., WOLF R. L., NAFTCHI N. E. Pharmacology and metabolism of norepinephrine in patients with essential hypertension. Am J Cardiol. 1962 May;9:717–723. doi: 10.1016/0002-9149(62)90132-7. [DOI] [PubMed] [Google Scholar]
  9. GRIFFITHS W. J., COLLINSON S. The estimation of noradrenaline in urine and its excretion in normal and hypertensive subjects. J Clin Pathol. 1957 May;10(2):120–125. doi: 10.1136/jcp.10.2.120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. HERTING G., AXELROD J., WHITBY L. G. Effect of drugs on the uptake and metabolism of H3-norepinephrine. J Pharmacol Exp Ther. 1961 Nov;134:146–153. [PubMed] [Google Scholar]
  11. HERTTING G., AXELROD J., KOPIN I. J., WHITBY L. G. Lack of uptake of catecholamines after chronic denervation of sympathetic nerves. Nature. 1961 Jan 7;189:66–66. doi: 10.1038/189066a0. [DOI] [PubMed] [Google Scholar]
  12. HILLARP N. A. Different pools of catecholamines stored in the adrenal medulla. Acta Physiol Scand. 1960 Sep 30;50:8–22. doi: 10.1111/j.1748-1716.1960.tb02068.x. [DOI] [PubMed] [Google Scholar]
  13. HILLARP N. A., LAGERSTEDT S., NILSON B. The isolation of a granular fraction from the suprarenal medulla, containing the sympathomimetic catechol amines. Acta Physiol Scand. 1953 Oct 6;29(2-3):251–263. doi: 10.1111/j.1748-1716.1953.tb01022.x. [DOI] [PubMed] [Google Scholar]
  14. MENDLOWITZ M., NAFTCHI N. Work of digital vasoconstriction produced by infused norepinephrine in primary hypertension. J Appl Physiol. 1958 Sep;13(2):247–251. doi: 10.1152/jappl.1958.13.2.247. [DOI] [PubMed] [Google Scholar]
  15. Prinzmetal M., Wilson C. THE NATURE OF THE PERIPHERAL RESISTANCE IN ARTERIAL HYPERTENSION WITH SPECIAL REFERENCE TO THE VASOMOTOR SYSTEM. J Clin Invest. 1936 Jan;15(1):63–83. doi: 10.1172/JCI100759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. SANDLER M., RUTHREN C. R., WOOD C. METABOLISM OF C14-NOREPINEPHRINE AND C14-EPINEPHRINE AND THEIR TRANSMISSION ACROSS THE HUMAN PLACENTA. Int J Neuropharmacol. 1964 Apr;3:123–128. doi: 10.1016/0028-3908(64)90055-3. [DOI] [PubMed] [Google Scholar]
  17. SMITH A. A. Dehydroxylation of norepinephrine. Biochim Biophys Acta. 1963 Jan 1;69:203–204. doi: 10.1016/0006-3002(63)91253-8. [DOI] [PubMed] [Google Scholar]
  18. TRENDELENBURG U. Supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol Rev. 1963 Jun;15:225–276. [PubMed] [Google Scholar]
  19. VON EULER U. S., HELLNER S., PURKHOLD A. Excretion of noradrenaline in urine in hypertension. Scand J Clin Lab Invest. 1954;6(1):54–59. [PubMed] [Google Scholar]
  20. VON EULER U. S., HILLARP N. A. Evidence for the presence of noradrenaline in submicroscopic structures of adrenergic axons. Nature. 1956 Jan 7;177(4497):44–45. doi: 10.1038/177044b0. [DOI] [PubMed] [Google Scholar]
  21. WHITBY L. G., AXELROD J., WEIL-MALHERBE H. The fate of H3-norepinephrine in animals. J Pharmacol Exp Ther. 1961 May;132:193–201. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES